Stay updated on Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.
Latest updates to the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3, indicating a new release.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check36 days agoNo Change Detected
- Check50 days agoChange DetectedThe website has been updated to version 2.10.0, adding 5 more interventions/treatments and 2 more study numbers, while removing the previous version 2.9.7.SummaryDifference0.4%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check62 days agoChange DetectedThe website now displays the actual last update posted instead of an estimated time, providing users with more accurate information.SummaryDifference0.0%
- Check63 days agoChange DetectedA new treatment regimen involving Pembrolizumab, Pemetrexed, and Platinum Chemotherapy has been added, with specific dosing and administration details provided. Additionally, the definition and monitoring of adverse events, as well as the criteria for disease progression assessment, have been updated and presented.SummaryDifference10%
Stay in the know with updates to Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Lung Cancer Clinical Trial page.